Exploiting DNA repair defects for novel cancer therapies

被引：20
作者：
van Gent, Dik C. [1 ]
Kanaar, Roland [1 ,2 ]
机构：
[1] Erasmus Univ, Med Ctr, Canc Genom Netherlands, Dept Mol Genet, NL-3015 Rotterdam, Netherlands
[2] Erasmus Univ, Med Ctr, Dept Radiat Oncol, NL-3015 Rotterdam, Netherlands
来源：
MOLECULAR BIOLOGY OF THE CELL | 2016年 / 27卷 / 14期
关键词：
STRAND BREAK REPAIR; HOMOLOGOUS RECOMBINATION; POLY(ADP-RIBOSE) POLYMERASE; TARGETED THERAPY; INHIBITION; TUMORS; CELLS; MTH1; HYPERTHERMIA; PATHWAYS;
D O I：
10.1091/mbc.E15-10-0698
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Most human tumors accumulate a multitude of genetic changes due to defects in the DNA damage response. Recently, small-molecule inhibitors have been developed that target cells with specific DNA repair defects, providing hope for precision treatment of such tumors. Here we discuss the rationale behind these therapies and how an important bottleneck-patient selection-can be approached.
引用
收藏
页码：2145 / 2148
页数：4
相关论文
共 50 条
  • [31] The Novel ATR Inhibitor BAY 1895344 Is Efficacious as Monotherapy and Combined with DNA Damage-Inducing or Repair-Compromising Therapies in Preclinical Cancer Models
    Wengner, Antje M.
    Siemeister, Gerhard
    Luecking, Ulrich
    Lefranc, Julien
    Wortmann, Lars
    Lienau, Philip
    Bader, Benjamin
    Boemer, Ulf
    Moosmayer, Dieter
    Eberspaecher, Uwe
    Golfier, Sven
    Schatz, Christoph A.
    Baumgart, Simon J.
    Haendler, Bernard
    Lejeune, Pascale
    Schlicker, Andreas
    von Nussbaum, Franz
    Brands, Michael
    Ziegelbauer, Karl
    Mumberg, Dominik
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (01) : 26 - 38
  • [32] Human RAD52-a novel player in DNA repair in cancer and immunodeficiency
    Ghosh, Sujal
    Hoenscheid, Andrea
    Dueckers, Gregor
    Ginzel, Sebastian
    Gohlkef, Holger
    Gombert, Michael
    Kempkes, Bettina
    Klapper, Wolfram
    Kuhlen, Michaela
    Laws, Hans-Juergen
    Linka, Rene Martin
    Meisel, Roland
    Mielke, Christian
    Niehues, Tim
    Schindler, Detlev
    Schneider, Dominik
    Schuster, Friedhelm R.
    Speckmann, Carsten
    Borkhardt, Arndt
    HAEMATOLOGICA, 2017, 102 (02) : E69 - E72
  • [33] DNA repair pathways as a novel therapeutic strategy in esophageal cancer: A review study
    Kheyrandish, Mohammad Reza
    Mir, Seyed Mostafa
    Arabi, Mehdi Sheikh
    CANCER REPORTS, 2022, 5 (11)
  • [34] Novel therapies for metastatic prostate cancer
    Jang, Albert
    Lanka, Sree M.
    Ruan, Hui Ting
    Kumar, Hamsa L. S.
    Jia, Angela Y.
    Garcia, Jorge A.
    Mian, Omar Y.
    Barata, Pedro C.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2023, : 1251 - 1263
  • [35] Exploiting the DNA Damage Response for Prostate Cancer Therapy
    Stracker, Travis H.
    Osagie, Oloruntoba I.
    Escorcia, Freddy E.
    Citrin, Deborah E.
    CANCERS, 2024, 16 (01)
  • [36] Targeting homologous recombination-mediated DNA repair in cancer
    Carvalho, Joao F. S.
    Kanaar, Roland
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (04) : 427 - 458
  • [37] DNA damage response and repair in pancreatic cancer development and therapy
    Farnood, Parnia Rahnamay
    Pazhooh, Romina Danesh
    Asemi, Zatollah
    Yousefi, Bahman
    DNA REPAIR, 2021, 103
  • [38] DNA interstrand crosslink repair and cancer
    Deans, Andrew J.
    West, Stephen C.
    NATURE REVIEWS CANCER, 2011, 11 (07) : 467 - 480
  • [39] Prostate cancer and DNA repair genes
    Penel, Nicolas
    BULLETIN DU CANCER, 2017, 104 (11) : 958 - 961
  • [40] Effects of hyperthermia as a mitigation strategy in DNA damage-based cancer therapies
    Mantso, Theodora
    Goussetis, George
    Franco, Rodrigo
    Botaitis, Sotiris
    Pappa, Aglaia
    Panayiotidis, Mihalis
    SEMINARS IN CANCER BIOLOGY, 2016, 37-38 : 96 - 105
12345